Guttman M - Search Results

1

Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Tong J, Williams B, Rusjan PM, Mizrahi R, Lacapère JJ, McCluskey T, Furukawa Y, Guttman M, Ang LC, Boileau I, Meyer JH, Kish SJ. Tong J, et al. Among authors: guttman m. J Cereb Blood Flow Metab. 2020 May;40(5):1061-1076. doi: 10.1177/0271678X19858003. Epub 2019 Jun 20. J Cereb Blood Flow Metab. 2020. PMID: 31220997 Free PMC article.

2

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.

Hoshi H, Kuwabara H, Léger G, Cumming P, Guttman M, Gjedde A. Hoshi H, et al. Among authors: guttman m. J Cereb Blood Flow Metab. 1993 Jan;13(1):57-69. doi: 10.1038/jcbfm.1993.8. J Cereb Blood Flow Metab. 1993. PMID: 8417011

3

Brain proteasomal function in sporadic Parkinson's disease and related disorders.

Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ, Briand Y. Furukawa Y, et al. Among authors: guttman m. Ann Neurol. 2002 Jun;51(6):779-82. doi: 10.1002/ana.10207. Ann Neurol. 2002. PMID: 12112087

4

Current concepts in the diagnosis and management of Parkinson's disease.

Guttman M, Kish SJ, Furukawa Y. Guttman M, et al. CMAJ. 2003 Feb 4;168(3):293-301. CMAJ. 2003. PMID: 12566335 Free PMC article. Review.

5

VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.

De La Fuente-Fernández R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ. De La Fuente-Fernández R, et al. Among authors: guttman m. Synapse. 2003 Jul;49(1):20-8. doi: 10.1002/syn.10199. Synapse. 2003. PMID: 12710012

6

Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.

Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Fitzmaurice PS, et al. Among authors: guttman m. Mov Disord. 2003 Sep;18(9):969-76. doi: 10.1002/mds.10486. Mov Disord. 2003. PMID: 14502663

7

Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Tong J, et al. Among authors: guttman m. Ann Neurol. 2004 Jan;55(1):125-9. doi: 10.1002/ana.10814. Ann Neurol. 2004. PMID: 14705122

8

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.

Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Kish SJ, et al. Among authors: guttman m. Brain. 2008 Jan;131(Pt 1):120-31. doi: 10.1093/brain/awm239. Epub 2007 Oct 22. Brain. 2008. PMID: 17956909

9

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.

Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ. Boileau I, et al. Among authors: guttman m. Mov Disord. 2008 Sep 15;23(12):1776-80. doi: 10.1002/mds.22212. Mov Disord. 2008. PMID: 18661545

10

Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?

Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ. Boileau I, et al. Among authors: guttman m. J Neurosci. 2008 Sep 24;28(39):9850-6. doi: 10.1523/JNEUROSCI.3008-08.2008. J Neurosci. 2008. PMID: 18815269 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page